Cytokinetics Inc

Organisation

350 Oyster Point Boulevard, South San Francisco, CA, United States, 94080

Headquarters

Employees

Health Technology

Industry

Robert Blum

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Price

Target

Cytokinetics Inc (CYTK) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Cytokinetics Inc (CYTK) share price will touch around $91.61 in next 12-months.

Currently 25 wall-street analysts regularly analyze the financials of Cytokinetics Inc on a frequent basis to provide recommendations along with target share price. 25 analysts offering 12-month price forecasts for Cytokinetics Inc (CYTK) have a share price target of $91.61. This median of share price forecast represents a 48.38% upside from the latest price of $61.74 as on 13.03.26.

Cytokinetics Inc (CYTK) Share Price Forecast

Home

US Stocks

Cytokinetics Inc (CYTK)

Cytokinetics Inc Stock Forecast

Cytokinetics Inc Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Cytokinetics Inc (CYTK): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Cytokinetics Inc's share price and its median forecast price. As on 13.03.26, the difference is -22.7%

Cytokinetics Inc Forecast and Target Price

Cytokinetics Inc (CYTK) Share Price Forecast

Cytokinetics Inc (CYTK) Price vs Consensus Price Target

Cytokinetics Inc (CYTK) Share Price Forecast v/s Share Price Today

Cytokinetics Inc (CYTK): Difference between Current Price & Median Forecasted Price

Cytokinetics Inc (CYTK) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price